A1 Refereed original research article in a scientific journal

Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT




AuthorsKauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV

Publication year2012

Journal:Acta Oncologica

Number in series5

Volume51

Issue5

First page 636

Last page644

Number of pages9

ISSN1651-226X

eISSN1651-226X

DOIhttps://doi.org/10.3109/0284186X.2011.643822


Abstract


Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5




Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5




Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5



Last updated on 2024-26-11 at 21:45